Cargando…
Efficacy of levetiracetam for neonatal seizures in preterm infants
BACKGROUND: Neonatal seizures remain a significant clinical problem, and therapeutic options are still not diverse with limited efficacy. Levetiracetam (LEV) is a relatively new and wide spectrum anti-seizure medication with favorable pharmacokinetics and safety profile. In the recent decades, LEV h...
Autores principales: | Han, Ji Yoon, Moon, Chung Joon, Youn, Young Ah, Sung, In Kyung, Lee, In Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892045/ https://www.ncbi.nlm.nih.gov/pubmed/29636029 http://dx.doi.org/10.1186/s12887-018-1103-1 |
Ejemplares similares
-
Intravenous Levetiracetam for Treatment of Seizures in Term and Preterm Neonates
por: Karaoğlu, Pakize, et al.
Publicado: (2020) -
Efficacy and safety of levetiracetam in the management of seizures in neonates
por: Sedighi, Mostafa, et al.
Publicado: (2016) -
Role of Levetiracetam in Neonatal Seizure
por: Murty, Yerramilli V.S.S., et al.
Publicado: (2012) -
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
por: Shin, Jae Won, et al.
Publicado: (2017) -
Levetiracetam as a First-line Agent for Neonatal Seizure
por: Mandal, Anirban, et al.
Publicado: (2017)